Navigation Links
Ranbaxy Launches Authorized Generic Version of Rocaltrol(R)
Date:9/2/2009

oducts in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries. Ranbaxy is a subsidiary of Daiichi Sankyo Company, Ltd.

Validus Pharmaceuticals LLC is focused on acquiring, developing and marketing effective, underutilized branded products in specialty therapeutic areas. During the past three years, the company has successfully acquired four products with specific therapeutic advantages that provide a current revenue stream. Validus seeks to acquire drug assets that are approved by the FDA and have well defined and accepted clinical utility relevant to today's practice of medicine. Validus is a portfolio company of Wood Creek Capital Management, LLC, a registered investment advisor that is focused on alternative investments. For more information about Validus Pharmaceuticals, visit www.validuspharma.com.

    CONTACTS: Charles M. Caprariello
              Vice President, Corporate Communications
              Ranbaxy Inc.
              (609) 720-5615

              Edwige Buteau
              RF Binder Partners Inc.
              (212) 994-7517

              Andrea Pavone
              RF Binder Partners Inc.
              (212) 994-7568
'/>"/>
SOURCE  Ranbaxy Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related medicine news :

1. Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets
2. Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets
3. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
4. Press Statement Issued by Ranbaxy Laboratories Limited
5. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
6. Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
7. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
8. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
9. Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
10. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
11. Ranbaxy Receives Tentative Approval For Valsartan Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Animals make great companions for senior citizens, but elderly people ... far more likely to crash than those who never drive ... included 2,000 licensed drivers aged 70 and older. The nearly ... drove with their pet in the car. Among those ... twice as high as among those who never drove with ...
(Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center for ... throughout the country participating in Shop Local for a Cause. ... event as he understands what military families go through after ... said, “I wanted to give something back, as I not ... here too.” , Shop Local for a Cause has chosen ...
(Date:5/25/2013)... NY (PRWEB) May 25, 2013 On ... to brain cancer research and advocacy, comments on a ... Physics, that shows incorporating cold atmospheric plasma into brain ... , According to a Science Daily ... Physics (MPE), biologists and physicians demonstrated the “synergistic effect ...
(Date:5/25/2013)... Acuity Games ’ innovative brain games ... Word Hunt is available today, expanding it beyond ... Flash 2, Sudoku and Matchematics will roll out over the ... revolutionary lifetime brain fitness measurement have been re-optimized for the ... of brain fitness measurement in your pocket. What could ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. ... a medical science, its scope enters into the realms of ... is that disease is the end result of living out ... health, one must discover where we are living out of ... back into perfect harmony. , The Foundations course in Mexico ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2
... risk, data review finds , , TUESDAY, Dec. 2 (HealthDay News) ... safety of the drug Trasylol (aprotinin), used to limit bleeding ... of controversy in the United States, where it was removed ... Canadian and Australian researchers reviewed findings from 49 randomized clinical ...
... 2 Seniors, disabled,Michiganders, state HMOs and health insurance ... jam anti-consumer, anti-business legislation,through the lame duck session of ... "This could be a matter of life or death ... Policy Manager for the Michigan Disability Rights,Coalition. "A vote ...
... accounted for 3.5 percent of high school athletes, ... study to examine rare injuries and conditions of ... injuries, dental injuries, neck and cervical injuries and ... high morbidity, costly surgeries and treatments or life-altering ...
... advocates for teen,dating violence education from across the country ... -- Moms and Dads for Education to Stop Teen,Dating ... Lindsay Ann Burke,who was murdered by her abusive ex-boyfriend, ... on this national coalition that will,consist of parents, teachers ...
... the procedure, study says , , TUESDAY, Dec. 2 (HealthDay News) ... don,t respond to drugs would gain about five years of ... they had a certain form of brain surgery. , That,s ... modeling to assess the benefits of surgery of the temporal ...
... new brand name for the project formerly known as “Clinical Document Architecture ... the technical standards developed by the project and submitted to Health Level ... ... EON) December 2, 2008 -- "Our group has been working with ...
Cached Medicine News:Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... DIEGO , May 23, 2013 Neurocrine Biosciences, ... Kevin Gorman , President and Chief Executive Officer ... 38 th Annual dbAccess Health Care Conference in Boston.   ... May 30 at 11:20 a.m. Eastern Time / 8:20 a.m. ... accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... 22, 2011 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has accepted for review ... Injection for Subcutaneous Use for the prevention of gout ... Prescription Drug User Fee Act (PDUFA), the goal for ...
... Endoscopy, Inc.,s (OTCPK: SNDY) is pleased to announce that ... of $73,895.  Solos Endoscopy has consummated agreements which resulted ... Three Months period ending September 30, 2011.  The signed ... reduction of ongoing expenses by approximately $40,000 per quarter. ...
Cached Medicine Technology:Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 2Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 3Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 4Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 5Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 6Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 7Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review 8Solos Endoscopy Finishes the 3rd Quarter With a Net Profit 2
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
Medicine Products: